A study showed that patients with prostate cancer should consider the long-term side effects of treatments before deciding on ...

EMJ is delighted to introduce Axel Heidenreich, Professor and Director at the University of Cologne, Germany, who spoke to us ...

By Richard Moore In the month of November, “Movember” raises awareness of men’s health and the impact of prostate cancer on ...

Investigators assessed the oncologic benefit of salvage radiation therapy versus observation for men with biochemical recurrence after radical prostatectomy.

Prostate cancer stands as one of the most prevalent cancers affecting men worldwide. Each year, millions of men and their ...

After skin cancer, prostate cancer is the most common cancer among men in the U.S., and 20% to 30% of men who beat it once ...

One of the most widespread myths about prostate cancer is that it only affects older men. While it is true that the risk of ...

In recent years, hypofractionated radiation has eclipsed conventionally fractionated radiation as the preferred treatment ...

A new study led by UCLA Health Jonsson Comprehensive Cancer Center investigators offers new evidence that dietary changes may ...

The NCCN has endorsed the Prolaris prostate cancer prognostic test, reinforcing its position as a critical tool in prostate ...

CAN-2409 resulted in disease-free survival improvements for patients with high-risk, localized prostate cancer.

The study strongly suggested that Nigeria is a high risk zone for prostate cancer. Hormone therapy plays a significant role ...